Oncternal Therapeutics, Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.
The company mentioned on its website that they use animals for product testing.
“TK216 was selected as our lead product candidate. TK216 has been extensively evaluated in preclinical studies, where it has been confirmed to kill Ewing sarcoma cells and inhibit Ewing sarcoma tumors in animal models.” Read the following article
Company Website: https://www.oncternal.com